以色列全国性研究:COVID-19与严重精神疾病的检测、感染、住院、死亡及疫苗接种率
这项全国性队列研究链接以色列国家数据库,纳入2020年3月1日至2021年3月31日期间所有曾因精神障碍住院的125,273名18岁及以上个体,与总人口6,143,802人比较。结果显示,病例组COVID-19检测率和确诊感染率低于总人口,但感染者住院、COVID-19归因死亡及全因死亡风险高于总人口,非情感性精神病和双相障碍病例风险更高;病例组疫苗接种率较低,非情感性精神病病例尤其低。
要点
- 曾因精神障碍住院者COVID-19检测率51.2%低于总人口62.3%,确诊感染率5.9%低于8.9%。
- 感染者中,病例组COVID-19住院、归因死亡及全因死亡调整OR分别为2.10、1.76、2.02。
- 非情感性精神病和双相障碍病例风险更高;病例组疫苗接种率60.4%低于总人口74.9%。
核心结论
- 研究强调需增加曾因精神障碍住院个体的COVID-19检测、密切监测阳性者并主动鼓励接种疫苗。
研究设计与样本
- 全国性队列研究,链接以色列国家数据库,纳入2020年3月1日至2021年3月31日所有曾因精神障碍(ICD-10 F10-F69或F90-F99)住院的125,273名18岁及以上个体,与总人口6,143,802人比较。
主要发现
- 病例组COVID-19检测率51.2%(95%CI 50.8-51.7)低于总人口62.3%(95%CI 62.2-62.4)。
- 病例组确诊COVID-19感染率5.9%(95%CI 5.8-6.1)低于总人口8.9%(95%CI 8.9-8.9)。
- 感染者中,病例组较总人口的COVID-19住院调整OR为2.10(95%CI 1.96-2.25)。
- 感染者中,病例组较总人口的COVID-19归因死亡调整OR为1.76(95%CI 1.54-2.01),全因死亡调整OR为2.02(95%CI 1.80-2.28)。
- 非情感性精神病和双相障碍病例上述风险更高;病例组年龄调整疫苗接种率60.4%(95%CI 59.9-60.8)低于总人口74.9%(95%CI 74.8-75.0),非情感性精神病病例尤其低至56.9%(95%CI 56.3-57.6)。
临床怎么用
- 作者强调需增加曾因精神障碍住院个体的COVID-19检测、密切监测阳性者并主动鼓励接种疫苗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Previous studies on psychiatric patients infected with COVID-19 have reported a more severe course of disease and higher rates of mortality compared with the general population. This cohort study linked Israeli national databases including all individuals ever hospitalized for a psychiatric disorder (cases), and COVID-19 testing, infection, hospitalization, mortality, and vaccinations, between March 1st 2020 and March 31st 2021. Cases were 125,273 individuals aged 18 and above ever hospitalized in a psychiatric facility (ICD-10 F10-F69 or F90-F99), compared to the total population, n = 6,143,802. Compared with the total population, cases were less likely to be tested for COVID-19, 51.2% (95% CI: 50.8-51.7) vs 62.3% (95% CI 62.2-62.4) and had lower rates of confirmed COVID infection, 5.9% (95% CI: 5.8-6.1) vs 8.9% (95% CI: 8.9-8.9). Among those infected, risks for COVID-19 hospitalization, COVID-19 attributed mortality and all-cause mortality were higher for cases than the total population, adjusted odds ratios were 2.10; (95% CI: 1.96-2.25), 1.76; (95% CI: 1.54-2.01) and 2.02; (95% CI: 1.80-2.28), respectively. These risks were even higher for cases with non-affective psychotic disorders and bipolar disorder. Age adjusted rates of vaccination were lower in cases, 60.4% (95% CI: 59.9-60.8) vs 74.9% (95% CI: 74.8-75.0) in the total population, and particularly low for cases with non-affective psychotic disorders, 56.9% (95% CI: 56.3-57.6). This study highlights the need to increase testing for COVID-19 in individuals ever hospitalized for a psychiatric disorder, closely monitor those found positive, and to reach out to encourage vaccination.
引用
- Goldberger N, Bergman-Levy T, Haklai Z, et al. COVID-19 and severe mental illness in Israel: testing, infection, hospitalization, mortality and vaccination rates in a countrywide study. Mol Psychiatry. 2022. PMID: 35459901. doi:10.1038/s41380-022-01562-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。